ENDRA Life Sciences Inc. - COM (NDRA)

CUSIP: 29273B500

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COM
Total 13F shares
71,825
Share change
+58,739
Total reported value
$325,366
Price per share
$4.53
Number of holders
7
Value change
+$255,093
Number of buys
5
Number of sells
4

Security key

29273B500

Report period

Q4 2025

Institutions

7

Top holders

7

Top shareholders of NDRA - ENDRA Life Sciences Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Anthony DiGiandomenico
13D/G
10%
121,622
$0 15 Oct 2025
John C. Lipman
13D/G
John Carter Lipman
10%
115,477
$0 23 Oct 2025
ATW Partners Opportunities Management, LLC
13D/G
ATW Master Fund V LP
9.9%
116,024
$0 16 Oct 2025
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
3%
35,589
$0 14 Nov 2025
S.H.N. Financial Investments Ltd.
13D/G
3%
35,588
$0 14 Nov 2025
DRW Securities, LLC
13F
Company
class O/S missing
12,714
$68,401 30 Sep 2025
13F
Michael Milos Thornton
3/4/5
Chief Technology Officer
class O/S missing
34,139
$56,329 18 May 2023
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
225
$1,210 30 Sep 2025
13F
UBS Group AG
13F 3/4/5
Company · Market maker/broker-dealer
class O/S missing
106
$570 30 Sep 2025
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
class O/S missing
35
$188 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
6
$32 30 Sep 2025
13F
Renaud Bertrand Maloberti
3/4/5
Chief Commercial Officer
class O/S missing
186,430
28 Mar 2022
Francois Roger Michelon
3/4/5
Chief Executive Officer, Director
class O/S missing
69,531
30 Jan 2023
Irina Pestrikova
3/4/5
Senior Director, Finance
class O/S missing
8,000
30 Jan 2023

Institutional Holders of ENDRA Life Sciences Inc. - COM (NDRA) as of Q4 2025

As of 31 Dec 2025, ENDRA Life Sciences Inc. - COM (NDRA) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,825 shares. The largest 7 holders included Altium Capital Management LLC, VANGUARD GROUP INC, MORGAN STANLEY, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, UBS Group AG, BANK OF AMERICA CORP /DE/, and CITIGROUP INC. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
5
Q4 2025 holders
7
Holder diff
2
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .